106 related articles for article (PubMed ID: 23631600)
1. Global metabolite profiling of human colorectal cancer xenografts in mice using HPLC-MS/MS.
Loftus NJ; Lai L; Wilkinson RW; Odedra R; Wilson ID; Barnes AJ
J Proteome Res; 2013 Jun; 12(6):2980-6. PubMed ID: 23631600
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
3. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
4. Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.
Fan X; Rao J; Zhang Z; Li D; Cui W; Zhang J; Wang H; Tou F; Zheng Z; Shen Q
Cell Physiol Biochem; 2018; 46(4):1317-1330. PubMed ID: 29689551
[TBL] [Abstract][Full Text] [Related]
5. Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.
Seierstad T; Røe K; Sitter B; Halgunset J; Flatmark K; Ree AH; Olsen DR; Gribbestad IS; Bathen TF
Mol Cancer; 2008 Apr; 7():33. PubMed ID: 18439252
[TBL] [Abstract][Full Text] [Related]
6. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies.
Mirnezami R; Jiménez B; Li JV; Kinross JM; Veselkov K; Goldin RD; Holmes E; Nicholson JK; Darzi A
Ann Surg; 2014 Jun; 259(6):1138-49. PubMed ID: 23860197
[TBL] [Abstract][Full Text] [Related]
8. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
9. MyCompoundID: using an evidence-based metabolome library for metabolite identification.
Li L; Li R; Zhou J; Zuniga A; Stanislaus AE; Wu Y; Huan T; Zheng J; Shi Y; Wishart DS; Lin G
Anal Chem; 2013 Mar; 85(6):3401-8. PubMed ID: 23373753
[TBL] [Abstract][Full Text] [Related]
10. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
[TBL] [Abstract][Full Text] [Related]
11. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS.
Duarte IF; Legido-Quigley C; Parker DA; Swann JR; Spraul M; Braumann U; Gil AM; Holmes E; Nicholson JK; Murphy GM; Vilca-Melendez H; Heaton N; Lindon JC
Mol Biosyst; 2009 Feb; 5(2):180-90. PubMed ID: 19156264
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
13. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
14. Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.
Tian Y; Xu T; Huang J; Zhang L; Xu S; Xiong B; Wang Y; Tang H
Sci Rep; 2016 Feb; 6():20790. PubMed ID: 26876567
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model.
Seierstad T; Røe K; Olsen DR
Radiother Oncol; 2007 Nov; 85(2):187-94. PubMed ID: 17937968
[TBL] [Abstract][Full Text] [Related]
16. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome.
Guo K; Li L
Anal Chem; 2009 May; 81(10):3919-32. PubMed ID: 19309105
[TBL] [Abstract][Full Text] [Related]
17. Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.
Jordan BF; Black K; Robey IF; Runquist M; Powis G; Gillies RJ
NMR Biomed; 2005 Nov; 18(7):430-9. PubMed ID: 16206237
[TBL] [Abstract][Full Text] [Related]
18. Ion-pairing reversed-phase liquid chromatography fractionation in combination with isotope labeling reversed-phase liquid chromatography-mass spectrometry for comprehensive metabolome profiling.
Guo K; Peng J; Zhou R; Li L
J Chromatogr A; 2011 Jun; 1218(23):3689-94. PubMed ID: 21543078
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in metabolomics in oncology.
O'Connell TM
Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
[TBL] [Abstract][Full Text] [Related]
20. LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.
Peng W; Tan S; Xu Y; Wang L; Qiu D; Cheng C; Lin Y; Liu C; Li Z; Li Y; Zhao Y; Li Q
Oncol Rep; 2018 Aug; 40(2):1026-1034. PubMed ID: 29989648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
